Pay in 4 interest-free payments of $7.29 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
Due to the high prevalence of toxicity and adverse drug reactions (ADRs) of chemotherapeutic agents and low patient compliance, there is always a need for compounds that can be used as adjuvants to existing cancer treatments with low ADRs, which can boost the efficacy of chemotherapeutics [2]
Sign up now and stay informed
However, a limitation of exendin-4 is its short half-life of approximately 6090 min 14
Hristov, A., Christova, N., Nacheva, L., Stoineva, I
Figure 1 presents the proportion of patients (X axis) whose percentage reduction from baseline in complex partial seizure rates was at least as great as that indicated on the Y axis in the adjunctive therapy study
Stretch Marks
US$ 20.60
US$ 27.03
US$ 26.52
US$ 20.96
US$ 25.60
US$ 19.99
US$ 27.02
